Depression News and Research

Latest Depression News and Research

Today's Opinions: GOP rerun; Finding bipartisanship; Pawlenty's legacy

You just can't close the door on this crowd. The party that brought us the worst economy since the Great Depression, that led us into Iraq and the worst foreign policy disaster in American history, that would like to take a hammer to Social Security and a chisel to Medicare, is back in control of the House of Representatives with the expressed mission of undermining all things Obama (Bob Herbert, 1/3).

4 Jan 2011

CAMFT launches new searchable online directory for counselors and therapists

Taking control of your mental health and finding the support you need just got easier for Californians thanks to a new searchable online directory, CounselingCalifornia.com. The free service created by the California Association of Marriage and Family Therapists (CAMFT) addresses a significant hurdle for Californians looking for counselors and therapists.

4 Jan 2011

Bupropion and varenicline help curb cigarette craving

The smoking cessation medications bupropion and varenicline may both be associated with changes in the way the brain reacts to smoking cues, making it easier for patients to resist cravings, according to two reports posted online today that will appear in the May print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Jan 2011

Baby boomers lack knowledge about Alzheimer's disease

An online survey of baby boomers across Canada conducted by the Alzheimer Society reveals a worrying lack of awareness about Alzheimer's disease.

4 Jan 2011

Depression and diabetes linked to increased risk of death from heart disease in women

Depression and diabetes appear to be associated with a significantly increased risk of death from heart disease and risk of death from all causes over a six-year period for women, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Jan 2011

Genes determine susceptibility to depression

University of Michigan Health System researchers have found new evidence that our genes help determine our susceptibility to depression.

4 Jan 2011

Mediterranean diet helps more than one chronic condition

In a study that was published in the Oct 13, 2001 issue of Diabetes Care, authors had reported that Mediterranean diet can reduce the risk of developing diabetes significantly. Those on this diet were 52 percent less likely to develop diabetes, compared with those who adhered least to the diet. Salas-Salvadó J. of Universitat Rovira i Virgili in Reus, Spain and colleagues compared two groups of subjects following two Mediterranean diets, one with nuts at 30 grams per day and the other with olive oil at 1 liter per week, with those on a low-fat diet.

2 Jan 2011

Team care to help multiple chronic conditions

According to a new study patients with multiple chronic diseases like diabetes mellitus and heart disease are at higher risk of depression that can render medication ineffective. Lead researcher Dr. Wayne J. Katon and colleagues at University of Washington in the study found that patients who received care from nurses who worked with patients and physicians to manage the care for depression and diabetes and heart disease had better outcomes. The study was published in the Dec 30, 2010 issue of New England Journal of Medicine.

2 Jan 2011

New women’s health policy inadequate

The Gillard government is being criticized for issuing a women’s health policy without announcing more funding for struggling women’s services. This is the first national women’s health policy in 21 years that claims to ensure women “have access to the right healthcare at the right time”.

30 Dec 2010

Teenage autistic boy allowed sex change procedure

A 16 year old autistic schoolboy has been granted approval to begin treatment for a sex change. He will have the provision to have his sperm frozen in case he decides he wants children. The decision came from Family Court judge Justice Linda Dessau on an emergency application from the boy’s parents so that he can begin therapy before his puberty fully sets in.

30 Dec 2010

General anesthesia's similarities with and differences from sleep and coma

The use of general anesthesia is a routine part of surgical operations at hospitals and medical facilities around the world, but the precise biological mechanisms that underlie anesthetic drugs' effects on the brain and the body are only beginning to be understood. A review article in the December 30 New England Journal of Medicine brings together for the first time information from a range of disciplines, including neuroscience and sleep medicine, to lay the groundwork for more comprehensive investigations of processes underlying general anesthesia.

30 Dec 2010

Interaction of light with circadian systems

In a new paper published this week in the Proceedings of the National Academy of Sciences, Aziz Sancar, MD, PhD, the Sarah Graham Kenan Professor of Biochemistry and Biophysics in the UNC School of Medicine, and his colleagues have taken an important step in understanding the underlying molecular signals that influence a broad array of biological processes ranging from the sleep-wake cycle to cancer growth and development.

30 Dec 2010

FDA approves Endo's FORTESTA Gel for low testosterone

Endo Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved FORTESTA Gel for the treatment of low testosterone, or 'Low T,' also known as hypogonadism. Symptoms associated with Low T include erectile dysfunction and decreased sexual desire, fatigue and loss of energy, mood depression, regression of secondary sexual characteristics and osteoporosis.

29 Dec 2010

New innovative program to identify and treat combat veterans suffering from PTSD

An innovative program to identify and treat combat veterans suffering from Post Traumatic Stress Disorder - but who have not sought treatment - has been started by U.S.VETS, the nation's largest nonprofit devoted to providing housing and other services to homeless and at-risk veterans.

29 Dec 2010

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus Therapeutics, LLC, today announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma), systemic inflammation and cachexia.

28 Dec 2010

Oxytocin makes individuals feel calmer and dampens effect on fear receptor in the brain

"My husband of thirty-five years passed away seven years ago, and I lost my daughter in a car accident last year, I honestly could no longer find the energy to smile or laugh," recounts sixty-year-old widow Opal Perry. "My son suggested I try a new hormone being touted to help with symptoms of depression, called oxytocin. After the second day I was driving and caught myself smiling in the mirror. I couldn't believe it. I had to do a double take. I hadn't really smiled in seven years! I thought I would never smile again until now."

23 Dec 2010

Minorities with MS may face risk of developing depressive symptoms

Multiple sclerosis can cause significant physical impairment, including fatigue, pain, muscle spasms, tremors and dizziness. For many with MS, the disease wreaks havoc with emotional well-being, too, and according to a new study, minorities might especially be at risk for developing depressive symptoms.

23 Dec 2010

Global Business Forum on health care at University of Miami

The University of Miami will bring together some of the most influential leaders in business and government, along with hundreds of professionals from across industries, Jan. 12 - 14, 2011 for a Global Business Forum entitled "The Business of Health Care: Defining the Future."

22 Dec 2010

$Emory University study reaffirms benefits of VNS Therapy System for refractory epilepsy$

Emory University study reaffirms benefits of VNS Therapy System for refractory epilepsy

Cyberonics, Inc. announced today that the VNS Therapy System, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, was featured in 22 poster presentations and in the Plenary II session on neurostimulation at the annual American Epilepsy Society Meeting that took place recently in San Antonio, Texas.

22 Dec 2010

Pregnant women veterans face increase risk of mental health problems

Pregnancy among women veterans who served in Iraq and Afghanistan appears to increase their risk for mental health problems such as depression, anxiety, and post-traumatic stress disorder, according to a study published in Journal of Women's Health, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online.

22 Dec 2010